Roche is making waves with a staggering $50 billion investment in the U.S. to combat looming pharma tariffs. This financial muscle aims to:

• Create approximately 12,000 jobs
• Establish a new weight-loss drug factory
• Solidify Roche's presence in the competitive U.S. market

This strategic move reflects the growing trend of pharmaceutical giants stepping up investment in America as they navigate tariff threats. Here's the full scoop!